171 related articles for article (PubMed ID: 9878439)
1. Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine.
Lamers MB; Antson AA; Hubbard RE; Scott RK; Williams DH
J Mol Biol; 1999 Jan; 285(2):713-25. PubMed ID: 9878439
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain.
Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G
Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993
[TBL] [Abstract][Full Text] [Related]
3. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
[TBL] [Abstract][Full Text] [Related]
4. Subdomain switching reveals regions that harbor substrate specificity and regulatory properties of protein tyrosine kinases.
Wang YH; Huang K; Lin X; Sun G
Biochemistry; 2007 Sep; 46(35):10162-9. PubMed ID: 17691821
[TBL] [Abstract][Full Text] [Related]
5. Domain interactions in protein tyrosine kinase Csk.
Sondhi D; Cole PA
Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
[TBL] [Abstract][Full Text] [Related]
6. Structure of human Fyn kinase domain complexed with staurosporine.
Kinoshita T; Matsubara M; Ishiguro H; Okita K; Tada T
Biochem Biophys Res Commun; 2006 Aug; 346(3):840-4. PubMed ID: 16782058
[TBL] [Abstract][Full Text] [Related]
7. The refined crystal structure of Bacillus cereus oligo-1,6-glucosidase at 2.0 A resolution: structural characterization of proline-substitution sites for protein thermostabilization.
Watanabe K; Hata Y; Kizaki H; Katsube Y; Suzuki Y
J Mol Biol; 1997 May; 269(1):142-53. PubMed ID: 9193006
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.
Narayana N; Cox S; Shaltiel S; Taylor SS; Xuong N
Biochemistry; 1997 Apr; 36(15):4438-48. PubMed ID: 9109651
[TBL] [Abstract][Full Text] [Related]
9. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
[TBL] [Abstract][Full Text] [Related]
10. Specificity of alpha-cyano-beta-hydroxy-beta-methyl-n-[4-(trifluoromethoxy)phe nyl]-propenamide as an inhibitor of the epidermal growth factor receptor tyrosine kinase.
Ghosh S; Zheng Y; Jun X; Mahajan S; Mao C; Sudbeck EA; Uckun FM
Clin Cancer Res; 1999 Dec; 5(12):4264-72. PubMed ID: 10632369
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk.
Mikkola ET; Gahmberg CG
J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462
[TBL] [Abstract][Full Text] [Related]
13. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
14. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.
Lin X; Ayrapetov MK; Lee S; Parang K; Sun G
Biochemistry; 2005 Feb; 44(5):1561-7. PubMed ID: 15683240
[TBL] [Abstract][Full Text] [Related]
15. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
Eck MJ; Atwell SK; Shoelson SE; Harrison SC
Nature; 1994 Apr; 368(6473):764-9. PubMed ID: 7512222
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of phosphoserine aminotransferase from Escherichia coli at 2.3 A resolution: comparison of the unligated enzyme and a complex with alpha-methyl-l-glutamate.
Hester G; Stark W; Moser M; Kallen J; Marković-Housley Z; Jansonius JN
J Mol Biol; 1999 Feb; 286(3):829-50. PubMed ID: 10024454
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of Escherichia coli phosphoenolpyruvate carboxykinase: a new structural family with the P-loop nucleoside triphosphate hydrolase fold.
Matte A; Goldie H; Sweet RM; Delbaere LT
J Mol Biol; 1996 Feb; 256(1):126-43. PubMed ID: 8609605
[TBL] [Abstract][Full Text] [Related]
19. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of Escherichia coli glutathione S-transferase complexed with glutathione sulfonate: catalytic roles of Cys10 and His106.
Nishida M; Harada S; Noguchi S; Satow Y; Inoue H; Takahashi K
J Mol Biol; 1998 Aug; 281(1):135-47. PubMed ID: 9680481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
